Vassiliki A Boussiotis

Beth Israel Deaconess Medical Center

NIH Rank #5771
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#5,771
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 3 grants · National rank #5771.

Top grants by award amount

Vassiliki A Boussiotis's NIH grant portfolio, ranked by award amount.

  • 5R01CA257672-02R01
    Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
    $676K
    award amount
  • 5R01CA238263-05R01
    The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
    $623.1K
    award amount
  • 5R01CA271601-02R01
    Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
    $618.8K
    award amount

Affiliation

Institutions that have administered grants for Vassiliki A Boussiotis.

Affiliated with Beth Israel Deaconess Medical Center (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Beth Israel Deaconess Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5771